|
Innovative high throughput tunable filter for widefield biomedical Raman imaging
|
1R43CA171740-01A1
|
$246,228
|
$246,228
|
ZHU, LEYUN
|
AGILTRON, INC.
|
|
Nemours Community Clinical Oncology Program
|
1U10CA176879-01
|
$558,366
|
$22,335
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Community Clinical Oncology Program
|
5U10CA037422-26
|
$2,811,894
|
$56,238
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-37
|
$14,566,378
|
$582,655
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Biospecimen Repository
|
5U24CA114734-08
|
$977,658
|
$97,766
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S2
|
$5,146,722
|
$205,869
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
A Novel Brachytherapy Agent for GBM
|
1R41CA165626-01A1
|
$299,937
|
$299,937
|
Calzone, Frank
|
APPLIED INTEGRIN SCIENCES, INC.
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$9,723
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
International Case Control Study of Malignant Glioma
|
5R01CA139020-04
|
$1,862,222
|
$1,862,222
|
Bondy, Melissa
|
BAYLOR COLLEGE OF MEDICINE
|
|
Apoptosis driven by elastase inhibitor: new approach to detection and study.
|
1R21CA178365-01
|
$191,944
|
$191,944
|
DIDENKO, VLADIMIR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-03
|
$148,746
|
$148,746
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$9,750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$5,624
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$402,065
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-05
|
$310,084
|
$310,084
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
1R01CA166749-01A1
|
$330,637
|
$330,637
|
Zage, Peter
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$6,125
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Control of cancer and metastasis by endothelial-derived epoxyeicosatrienoic acids
|
7R01CA148633-04
|
$263,365
|
$131,683
|
Panigrahy, Dipak
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme
|
2R44CA136017-04
|
$960,270
|
$960,270
|
Xu, Kevin
|
BEXION PHARMACEUTICALS, INC.
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S3
|
$501,282
|
$5,013
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S4
|
$122,789
|
$1,228
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Combination Therapies for Cancer Treatment
|
5R01CA049248-23
|
$308,545
|
$101,820
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Dysregulation of mTORC2 in gliomas
|
5R01CA168700-02
|
$215,921
|
$215,921
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
|
1R01CA166172-01A1
|
$365,719
|
$365,719
|
Chiocca, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
1P01CA174645-01
|
$1,300,672
|
$871,450
|
JOLESZ, FERENC
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
1U24CA180918-01
|
$724,331
|
$239,029
|
Kikinis, Ron
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Validation of microRNA Targets in Glioma
|
5R01CA138734-04
|
$330,591
|
$330,591
|
Krichevsky, Anna
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Targeting the Tumor Matrix as Anti-Invasive and Sensitizing Strategy for Glioma
|
5R01CA152065-05
|
$260,438
|
$260,438
|
Viapiano, Mariano
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image Registration for Ultrasound-Based Neurosurgical Navigation
|
5R01CA138419-05
|
$338,653
|
$338,653
|
Wells, William
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
5U24CA160034-03
|
$3,019,843
|
$754,961
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
3U54CA112962-09S1
|
$68,730
|
$17,183
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
5U54CA112962-09
|
$2,004,265
|
$501,066
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
Biostatistics Data Management Center for ACRIN
|
3U10CA079778-14S1
|
$2,271,308
|
$90,852
|
Gatsonis, Constantine
|
BROWN UNIVERSITY
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-04
|
$2,287,859
|
$571,965
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Engineering Triggered Nanomechanical Therapeutics
|
5R01CA140759-05
|
$303,525
|
$106,234
|
PIERCE, NILES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-30
|
$828,213
|
$8,282
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
1R01CA179956-01
|
$645,638
|
$645,638
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Sensitizer Delivery for Focused Hyperthermia Cancer Treatment
|
5R01CA136857-05
|
$342,312
|
$171,156
|
Exner, Agata
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-23
|
$4,740,480
|
$426,643
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-23S2
|
$37,026
|
$3,332
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-04
|
$306,229
|
$306,229
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Nanoconjugate based on polymalic acid for brain tumor treatment
|
5U01CA151815-04
|
$452,587
|
$452,587
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-11
|
$24,894,951
|
$1,991,596
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
1K07CA178100-01
|
$117,201
|
$117,201
|
Hocking, Matthew
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Neurocognitive and Family Functioning at End of Therapy in Pediatric Brain Tumor
|
5R03CA162970-02
|
$78,725
|
$78,725
|
Hocking, Matthew
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Community Clinical Oncology Program Research Base
|
5U10CA095861-12
|
$1,884,051
|
$150,724
|
POLLOCK, BRAD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
IGF1R gene 3'UTR variants in high-risk pediatric neuroblastoma
|
1R21CA168218-01A1
|
$182,156
|
$182,156
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Pediatric Phase 1/Pilot Consortium
|
5UM1CA097452-12
|
$2,131,427
|
$1,193,599
|
Weigel, Brenda
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Genomic Analysis of Medulloblastomas
|
5R01CA109467-08
|
$694,001
|
$694,001
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
5U10CA045418-27
|
$1,543,934
|
$15,439
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
Total relevant funding to Brain for this search: $171,170,883
|